Well it was weird that Kazem Kazempour, Amarex’s
Post# of 148165
(Total Views: 667)
Posted On: 11/12/2021 4:39:53 PM
Well it was weird that Kazem Kazempour, Amarex’s CEO, was withholding data on an HIV trial, his area of expertise for the last 30 years. He had to have know that the results were very positive.
He also was in on all the early Covid success in Mar/Apr 2020; so why would he keep this data back? Something really doesn't smell right here.
He knew NP, wrote a paper on Pro140 with NP about HIV in 2018, so what's going on there?
He also was in on all the early Covid success in Mar/Apr 2020; so why would he keep this data back? Something really doesn't smell right here.
He knew NP, wrote a paper on Pro140 with NP about HIV in 2018, so what's going on there?
(6)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼